Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

Media Advisory: Canadian Blood Services invites public to open board meeting Dec. 6


OTTAWA , Dec. 04, 2019 (GLOBE NEWSWIRE) --

WHAT:Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca and inviting the public to attend in person in Ottawa.
  
 Members of the public are invited to participate in open board meetings twice each year to hear about the organization's work, deliver presentations and meet with members of the board and the management team.
  
 Since its inception in 1998, Canadian Blood Services has been committed to operating in an open, transparent and collaborative manner.
  
WHO: Dr. Graham Sher, CEO, Canadian Blood Services, and members of the Executive Management Team
  
 Mel Cappe, Chair of the Board of Directors and members of the Board of Directors
  
WHEN:Friday, Dec. 6, 2019
 8:30 a.m. to 12:30 p.m. EST
  
WHERE: Canadian Blood Services
 1800 Alta Vista Drive
 Ottawa, ON
  
 Live stream available at https://blood.ca/en/about-us/governance/board-meetings/next-open-board-meeting

About Canadian Blood Services
Canadian Blood Services is a not-for-profit charitable organization. Regulated by Health Canada as a biologics manufacturer and primarily funded by the provincial and territorial ministries of health, Canadian Blood Services operates with a national scope, infrastructure and governance that make it unique within Canadian healthcare. In the domain of blood, plasma and stem cells, we provide services for patients on behalf of all provincial and territorial governments except Quebec. The national transplant registry for interprovincial organ sharing and related programs reaches into all provinces and territories, as a biological lifeline for Canadians.

/CanadasLifeline
@CanadasLifeline
1 888 2DONATE

For more information:
Tel. 1-877-709-7773
Email[email protected] 


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: